Tromsø, Norway – ArcticZymes Technologies ASA (OSE: AZT) launches AZtaq™ DNA Polymerase. ArcticZymes Technologies (AZT) today announces the launch of its new product, AZtaq™ DNA Polymerase. AZtaq™ is a high-quality thermostable DNA polymerase suitable for use in polymerase chain reaction (PCR) applications. Launching the AZtaq™ is a natural expansion of the Company’s molecular tools portfolio. […]

License allows Santa Cruz Biotechnology to develop and commercialize products using CRISPR/Cas9. Dublin, Ireland and Dallas, Texas:  ERS Genomics Limited (‘ERS’) is pleased to announce a new license agreement with Santa Cruz Biotechnology Inc (‘SCBT,’). This is a non-exclusive licensing agreement granting SCBT access to the ERS CRISPR/Cas9 patent portfolio. ERS founder, Dr. Emmanuelle Charpentier, […]

The accelerated nanopore basecaller “Dorado” is now integrated into the device software MinKNOW, to enable basecalling and broad methylation analysis in real time  Oxford Nanopore today announced the integration of an accelerated basecaller into the device software MinKNOW. These improvements enable the sequencing of approximately 2,500* human genomes a year on a PromethION 24 (at […]

SAN DIEGO — Illumina, Inc. (NASDAQ: ILMN), a global leader in DNA sequencing and array-based technologies, today announced Dr. Steven Barnard, Illumina’s Vice President and Head of Global Advanced Science, will serve as its next Chief Technology Officer (CTO), effective immediately. Dr. Alex Aravanis, who held the position of CTO, will be departing Illumina to […]

PHILADELPHIA — Inverness Graham backed Electron Microscopy Sciences (“EMS”) and Azer Scientific (“Azer”) are pleased to announce that they are coming together as one company to create a market leading solutions provider for research, clinical, and industrial lab supplies and services. With a common legacy of supplying high-quality products, custom capabilities, and responsive service, the combined company will offer […]

SAN DIEGO — Singular Genomics Systems, Inc. (Nasdaq: OMIC), a company leveraging novel next-generation sequencing (NGS) and multiomics technologies to empower researchers and clinicians, today announced the appointment of Marcia Eisenberg, Ph.D., to the Company’s Board of Directors. Dr. Eisenberg currently serves as Senior Vice President and Enterprise Chief Scientific Officer at Labcorp (NYSE: LH) […]

State-of-the-art facility in Hollister, California is designed to help bioprocessing and gene therapy companies scale from research to clinical production HOLLISTER, Calif. — Alpha Teknova, Inc. (“Teknova”) (Nasdaq: TKNO), a leading producer of critical reagents for the research, development, and commercialization of novel therapies, vaccines, and molecular diagnostics, today announced the opening of their newest […]

Expansion will accelerate advances in genome sequencing and analysis SAN DIEGO, CA – Element Biosciences, Inc., developer of the Element AVITI™ System, an innovative DNA sequencing platform that is disrupting the genomics industry, announced an expanded commercial partnership with Agilent Technologies to cooperate in selling Element and Agilent products, starting in the United States. This partnership builds […]

The School of Medicine will use the SOPHiA DDM™ Platform to expand its hematologic testing program for blood cancers  BOSTON and Rolle, Switzerland – SOPHiA GENETICS (Nasdaq: SOPH), a cloud-native software company and a leader in data-driven medicine, today announced that the Tulane University School of Medicine in New Orleans, Louisiana is live on SOPHiA GENETICS technology. […]

Study is first of its kind to compare diagnostic rates across short- and long-read sequencing platforms  MENLO PARK, Calif. and STAMFORD, Conn. — PacBio (Nasdaq: PACB), a leading developer of high-quality, highly accurate sequencing solutions and GeneDx (Nasdaq: WGS), a leader in delivering improved health outcomes through genomic and clinical insights, today announced a research collaboration with the University […]